This inventor holds 1 USPTO granted patent. Top assignee: Northwestern University. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Susan L McGovern: Innovator in Biomolecular Research
Introduction
Susan L McGovern is a prominent inventor based in Chicago, IL (US). She has made significant contributions to the field of biomolecular research, particularly in the identification of non-specific inhibitors of biomolecules. Her work has implications for drug screening and the understanding of biological reactions.
Latest Patents
Susan L McGovern holds a patent titled "Methods of identifying non-specific inhibitors of biomolecules." This invention provides methods for identifying compounds that non-specifically inhibit biological reactions. The patent also includes kits that facilitate this identification. Furthermore, it encompasses complications of compounds for use in high throughput drug screening that have been evaluated by the disclosed methodology. The invention offers methods for identifying false positive compounds previously identified as positive in a screening assay by measuring the activity of at least one biological activity in the presence and absence of a small molecule compound capable of inhibiting aggregate formation, such as digitonin. She has 1 patent to her name.
Career Highlights
Susan L McGovern is affiliated with Northwestern University, where she conducts her research and contributes to advancements in biomolecular science. Her work is recognized for its innovative approach to understanding complex biological interactions.
Collaborations
One of her notable collaborators is Brian K Shoichet, with whom she has worked on various research projects. Their collaboration has furthered the understanding of biomolecular interactions and the development of new methodologies in the field.
Conclusion
Susan L McGovern is a key figure in biomolecular research, with her innovative patent contributing to the advancement of drug screening methodologies. Her work continues to impact the scientific community and enhance our understanding of biological processes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
